Search by Drug Name or NDC

NDC 43063-0857-05 Ondansetron 4 mg/1 Details

Ondansetron 4 mg/1

Ondansetron is a ORAL TABLET, ORALLY DISINTEGRATING in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is ONDANSETRON.

MedlinePlus Drug Summary

Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. Ondansetron is in a class of medications called serotonin 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.

Related Packages: 43063-0857-05
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Ondansetron

Product Information

NDC	43063-0857
Product ID	43063-857_f8c4e860-e702-ade2-e053-6394a90a7c03
Associated GPIs	50250065007220
GCN Sequence Number	041562
GCN Sequence Number Description	ondansetron TAB RAPDIS 4 MG ORAL
HIC3	H6J
HIC3 Description	ANTIEMETIC/ANTIVERTIGO AGENTS
GCN	20045
HICL Sequence Number	019058
HICL Sequence Number Description	ONDANSETRON
Brand/Generic	Generic
Proprietary Name	Ondansetron
Proprietary Name Suffix	n/a
Non-Proprietary Name	Ondansetron
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, ORALLY DISINTEGRATING
Route	ORAL
Active Ingredient Strength	4
Active Ingredient Units	mg/1
Substance Name	ONDANSETRON
Labeler Name	PD-Rx Pharmaceuticals, Inc.
Pharmaceutical Class	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA090469
Listing Certified Through	2024-12-31

Package

NDC 43063-0857-05 (43063085705)

Pricing Information	N/A
NDC Package Code	43063-857-05
Billing NDC	43063085705
Package	5 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (43063-857-05)
Marketing Start Date	2018-06-12
NDC Exclude Flag	N